MedPath

Effectiveness of Combined Treatment of Carboxytherapy, Platelet-Rich Plasma (PRP) and Local Finasteride with Platelet-Rich Plasma in the Treatment of Androgenic Hair Loss

Phase 2
Conditions
Androgenic hair loss.
Cicatricial alopecia [scarring hair loss]
Registration Number
IRCT20220919055994N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
20
Inclusion Criteria

It is Men Who Have Suffered Androgenic Hair Loss (Severity 2-4 according to the Hamilton-Norwood Criteria) without any Underlying Disease

Exclusion Criteria

Patients include Platelet Disorders, Thrombocytopenia, Anemia, Cardio-Pulmonary Diseases, Kidney Disease, Vasovagal Syncope, Uncontrolled Blood Pressure, Taking Anticoagulant Drugs, Thyroid Dysfunction, Diabetes, Sepsis.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Male Hair Loss. Timepoint: 3 Months. Method of measurement: PhotoFinder Device.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath